APA

Jandu K. S., Barrett V., Brockwell M., Cambridge D., Farrant D. R., Foster C., Giles H., Glen R. C., Hill A. P., Hobbs H., Honey A., Martin G. R., Salmon J., Smith D., Woollard P. & Selwood D. L. (20010419). Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. : Journal of medicinal chemistry.

Chicago

Jandu K S, Barrett V, Brockwell M, Cambridge D, Farrant D R, Foster C, Giles H, Glen R C, Hill A P, Hobbs H, Honey A, Martin G R, Salmon J, Smith D, Woollard P and Selwood D L. 20010419. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. : Journal of medicinal chemistry.

Harvard

Jandu K. S., Barrett V., Brockwell M., Cambridge D., Farrant D. R., Foster C., Giles H., Glen R. C., Hill A. P., Hobbs H., Honey A., Martin G. R., Salmon J., Smith D., Woollard P. and Selwood D. L. (20010419). Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. : Journal of medicinal chemistry.

MLA

Jandu K S, Barrett V, Brockwell M, Cambridge D, Farrant D R, Foster C, Giles H, Glen R C, Hill A P, Hobbs H, Honey A, Martin G R, Salmon J, Smith D, Woollard P and Selwood D L. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. : Journal of medicinal chemistry. 20010419.